相关实验视频

Updated: May 24, 2025

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis

Published on: January 21, 2020

耐用与可生物降解的聚合物药物排泄支架在所有入场者中

Thierry Witzig¹, Serban Puricel¹, Alain Witzig¹

¹Cardiology, University & Hospital Fribourg, Fribourg, Switzerland.

|March 3, 2025

概括

与耐用聚合物药物排泄支架 (DP-DES) 相比,可生物降解聚合物药物排泄支架 (BP-DES) 的急性支架血栓形成率更高. 然而,两种类型的支架在术后两年内都表现出类似的临床结果.

科学领域:

心血管医学心血管医学
生物材料科学生物材料科学
干预心脏病学干预心脏病学

背景情况:

药物排泄支架 (DES) 是冠状动脉血管形成术的标准.
生物降解聚合物DES (BP-DES) 假设是优于耐用聚合物DES (DP-DES) 由于更好的生物相容性.
之前没有任何研究证实过一种聚合物类型对另一种类型的优越性.

研究的目的:

在全新人群中比较第二代DP-DES和BP-DES之间的临床结果.
评估不同类型的聚合物在DES中的安全性和有效性.
评估面向设备的复合终点和支架血栓形成的发生率.

主要方法:

从心脏FR数据库中分析了2824名接受皮肤冠状动脉干预 (PCI) 的患者.
包括2079名患者 (1286名DP-DES,793名BP-DES),随访2年.
主要结局:以设备为导向的复合终点 (DOCE),包括心脏死亡,目标血管MI和目标损伤再血管化.

主要成果:

尽管DP-DES组的风险因素较高,但急性支架血栓形成 (ST) 显着较低 (HR 0.240,p=0.016).
在考克斯回归和胜利比率分析后,这种ST差异仍然很大.
在两年内,BP-DES和DP-DES之间没有观察到DOCE的显著差异 (12.1%对14.5%,p=0.158).

结论:

长达2年的临床结果与BP-DES和DP-DES相似.
BP-DES与更高的急性支架血栓形成率有关.
可能需要进一步的研究来了解聚合物类型对长期心血管结果的影响.

关键词:

冠状动脉疾病冠状动脉疾病冠状动脉狭窄症冠状动脉狭窄症通过皮肤进行冠状动脉干预.

更多相关视频

Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents

Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents

Published on: October 26, 2016

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

相关概念视频

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...

Bioequivalence: Overview

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...